Skip to main content
Thomas Coates, MD, Pediatric Hematology & Oncology, Los Angeles, CA

ThomasDCoatesMD

Pediatric Hematology & Oncology • Los Angeles, CA

Pediatric Anemia and Red Blood Cell Hematology, Pediatric Coagulation Disorder Hematology, Pediatric Platelet Disorder Hematology

Section Head Hematology Childrens Blood and Cancer Institute, Childrens Hospital Los Angeles, Professor of Pediatrics and Pathology, USC Keck School of Medicine

Join to view full profile

Dr. Coates is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Coates' full profile

Already have an account?

  • Office

    4650 W Sunset Blvd
    Los Angeles, CA 90027
    Phone+1 323-361-2121
    Fax+1 323-660-7128

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Pediatric Hematology/Oncology, 1978 - 1982
  • Indiana University School of Medicine
    Indiana University School of MedicineResidency, Pediatrics, 1975 - 1978
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 1975

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1985 - 2025
  • IN State Medical License
    IN State Medical License 1977 - 2003
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Increased Brain Iron Deposition in Patients with Sickle Cell Disease: An MRI Quantitative Susceptibility Mapping Study  
    Thomas D Coates, John C Wood, Benita Tamrazi, Blood
  • A Novel Cross-Correlation Methodology for Assessing Biophysical Responses Associated with Pain  
    Lonnie K Zeltzer, Roberta M Kato, Jon Detterich, Thomas D Coates, John Sunwoo, John C Wood, Journal of Pain Research

Abstracts/Posters

  • Role of Exosomes in Hepcidin Regulation in _-Thalassemia
    Thomas Coates, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Lower Oxygen Saturation in the Internal Cerebral Vein of Patients with Sickle Cell Disease Revealed By Qsm-MRI
    Thomas Coates, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Evaluating Luspatercept Responders in the Phase 3, Randomized, Double-Blind, Placebo-Controlled BELIEVE Trial of Luspatercept in Adult Beta-Thalassemia Patients (Pts) ...
    Thomas Coates, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • IRON: How to Manage When There is Too Much or Too Little of It 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Hemolysis and Tricuspid Regurgitation Jet Velocity Predict Mortality in Patients with Sickle Cell Disease 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

Press Mentions

  • Researchers at Children’s Hospital Los Angeles Are Unraveling the Biological Mechanism That Triggers Pain in People with Sickle Cell Disease—and Confirming What Mothers Have Been Saying All Along
    Researchers at Children’s Hospital Los Angeles Are Unraveling the Biological Mechanism That Triggers Pain in People with Sickle Cell Disease—and Confirming What Mothers Have Been Saying All AlongJanuary 10th, 2022
  • Here Are the Best and Worse Case Scenarios for Omicron. Both Are Bad
    Here Are the Best and Worse Case Scenarios for Omicron. Both Are BadDecember 27th, 2021
  • Overview of Beta Thalassemia
    Overview of Beta ThalassemiaJanuary 31st, 2020
  • Join now to see all

Grant Support

  • Southern California Blood Safety Surveillance Program In Hematological DisorfersCenters For Disease Control And Prevention2012
  • Basic And Translational Research ProgramNational Heart, Lung, And Blood Institute2009–2011
  • Sickle Cell Scholar ComponentNational Heart, Lung, And Blood Institute2008–2011
  • Impact Of Blood Viscosity On Oxygen Delivery In Humans With Sickle Cell AnemiaNational Heart, Lung, And Blood Institute2008–2011
  • Administration CoreNational Heart, Lung, And Blood Institute2008–2011
  • Research Initiatives For The Preventions Of Complications Of ThalassemiaCenters For Disease Control And Prevention2007–2011
  • Human Models Of Sickle Cell Vascular DamageNational Center For Research Resources2006–2009
  • Comprehensive Sickle Cell CenterNational Heart, Lung, And Blood Institute2008
  • Human Models Of Sickle Cell Vascular Damage: (AIM2) Response Of Plasma MarkersNational Center For Research Resources2006
  • Human Models Of Sickle Cell Vascular DamageNational Heart, Lung, And Blood Institute2003–2006
  • Modeling Of Neutrophil MotilityNational Center For Research Resources1999–2002
  • Leukocyte Activation And Rheology In Sickle Cell Disease--Vascular OcclusionNational Heart, Lung, And Blood Institute1998–2002
  • Granules And Organelles And Leukocyte ActivationNational Institute Of Allergy And Infectious Diseases1995–1998
  • Neutrophil Activation And Rheology In Sickle Cell Disease--Vascular OcclusionNational Heart, Lung, And Blood Institute1996–1997
  • Core--Data CoordinatingNational Heart, Lung, And Blood Institute1996–1997
  • Role Of Granules &Organelles In Leukocyte ActivationNational Institute Of Allergy And Infectious Diseases1988–1992
  • Role Of Granules And Organelles In Leukocyte ActivationNational Institute Of Allergy And Infectious Diseases1985–1986

Dr. Thomas Coates, Dr. Thomas Coates, MD, Dr. T Coates, Dr. Thomas D Coates